AIMS: Accurate determination of HER-2 status is critical to identify patients for whom trastuzumab treatment will be of benefit. Although the recommended primary method of evaluation is immunohistochemistry, numerous reports of variability in interpretation have raised uncertainty about the reliability of results. Recent guidelines have suggested that image analysis could be an effective tool for achieving consistent interpretation, and this study aimed to assess whether this technology has potential as a diagnostic support tool. METHODS AND RESULTS: Across a cohort of 275 cases, image analysis could accurately classify HER-2 status, with 91% agreement between computer-aided classification and the pathology review. Assessment of the continu...
BACKGROUND: Accurate assessment of HER-2 is imperative in selecting patients for targeted therapy. M...
Background Immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) are the only tes...
HER2 gene amplification and receptor overexpression by tumors seems to be associated with poorer pro...
Aim Her2 protein is the key marker determining the choice of Herceptin therapy after a diagnosis of ...
Aims: To compare visual and computerized image analysis of HER2 immunohistochemistry (IHC) with fluo...
AbstractAimHer2 protein is the key marker determining the choice of Herceptin therapy after a diagno...
Background : Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor re...
Evaluation of human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) is subject ...
AimsTo test the validity of diagnostics incorporating digital image analysis (DIA) for human epiderm...
Abstract Background Breast cancers that overexpress the human epidermal growth factor receptor 2 (HE...
Background: Optimization of workflow for breast cancer samples with equivocal human epidermal growth...
Accurate diagnostic assessment of HER-2 is essential for the appropriate application of the humanize...
Aims:HER2 status is a prognostic factor in breast carcinoma and predicts response to trastuzumab the...
Immunohistochemistry (IHC) plays an important role in evaluating the status of ER, PR, Ki-67 and hum...
Trastuzumab-based therapy has been shown to confer overall survival benefit in HER2-positive patient...
BACKGROUND: Accurate assessment of HER-2 is imperative in selecting patients for targeted therapy. M...
Background Immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) are the only tes...
HER2 gene amplification and receptor overexpression by tumors seems to be associated with poorer pro...
Aim Her2 protein is the key marker determining the choice of Herceptin therapy after a diagnosis of ...
Aims: To compare visual and computerized image analysis of HER2 immunohistochemistry (IHC) with fluo...
AbstractAimHer2 protein is the key marker determining the choice of Herceptin therapy after a diagno...
Background : Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor re...
Evaluation of human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) is subject ...
AimsTo test the validity of diagnostics incorporating digital image analysis (DIA) for human epiderm...
Abstract Background Breast cancers that overexpress the human epidermal growth factor receptor 2 (HE...
Background: Optimization of workflow for breast cancer samples with equivocal human epidermal growth...
Accurate diagnostic assessment of HER-2 is essential for the appropriate application of the humanize...
Aims:HER2 status is a prognostic factor in breast carcinoma and predicts response to trastuzumab the...
Immunohistochemistry (IHC) plays an important role in evaluating the status of ER, PR, Ki-67 and hum...
Trastuzumab-based therapy has been shown to confer overall survival benefit in HER2-positive patient...
BACKGROUND: Accurate assessment of HER-2 is imperative in selecting patients for targeted therapy. M...
Background Immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) are the only tes...
HER2 gene amplification and receptor overexpression by tumors seems to be associated with poorer pro...